Financialsexperimental

BRISTOL MYERS SQUIBB CO (CELG-RI). Every figure is as filed in the company's 10-Q and 10-K reports. Quarters a filing does not report on their own are worked out from its year-to-date figures and marked *.

Income Statement Balance Sheet Cash FlowQuarterly Annual

USD in millions · per-share amounts in USD

Income Statement	Q2 FY26 30 Jun 2026	Q1 FY26 31 Mar 2026	Q4 FY25 31 Dec 2025	Q3 FY25 30 Sept 2025	Q2 FY25 30 Jun 2025	Q1 FY25 31 Mar 2025	Q4 FY24 31 Dec 2024	Q3 FY24 30 Sept 2024	Q2 FY24 30 Jun 2024	Q1 FY24 31 Mar 2024	Q4 FY23 31 Dec 2023	Q3 FY23 30 Sept 2023	Q2 FY23 30 Jun 2023	Q1 FY23 31 Mar 2023	Q4 FY22 31 Dec 2022	Q3 FY22 30 Sept 2022	Q2 FY22 30 Jun 2022	Q1 FY22 31 Mar 2022	Q4 FY21 31 Dec 2021	Q3 FY21 30 Sept 2021
Total Revenues	12,973	11,489	12,502*	12,222	12,269	11,201	12,342*	11,892	12,201	11,865	11,477*	10,966	11,226	11,337	11,406*	11,218	11,887	11,648	11,985*	11,624
Cost of products sold	3,726	3,421	4,097*	3,435	3,372	3,033	4,812*	2,957	3,267	2,932	2,745*	2,506	2,876	2,566	2,593*	2,353	2,720	2,471	2,356*	2,291
Selling, general and administrative	1,826	1,617	2,181*	1,789	1,713	1,584	2,136*	1,983	1,928	2,367	2,073*	2,003	1,934	1,762	2,266*	1,930	1,787	1,831	2,354*	1,788
Research and development	2,959	2,649	2,586*	2,528	2,580	2,257	3,191*	2,374	2,899	2,695	2,478*	2,242	2,258	2,321	2,510*	2,418	2,321	2,260	2,607*	3,251
Acquired IPRD	0	94	1,393*	633	1,508	188	30*	262	132	12,949	600*	80	158	75		30	400	333
Amortization of acquired intangible assets	437	437	826*	831	830	830	1,693*	2,406	2,416	2,357	2,278*	2,256	2,257	2,256	2,343*	2,418	2,417	2,417	2,417*	2,546
Other (income)/expense, net	-61	32	-51*	-108	494	339	305*	234	273	81	-371*	-258	-116	-413	-217*	-140	284	649	393*	-409
Total Expenses	8,887	8,250	11,032*	9,108	10,496	8,230	12,167*	10,216	10,915	23,381	9,803*	8,829	9,367	8,567	9,547*	9,009	9,929	9,961	10,127*	9,467
Earnings/(loss) before income taxes								1,676	1,286											2,157
Earnings/(Loss) before income taxes	4,086	3,240	1,470*	3,114	1,773	2,971				-11,516	1,674*	2,137	1,859	2,770	1,859*	2,209	1,958	1,687
Income tax provision	770	561	384*	919	460	509	99*	461	-398	392	-88*	203	-218	503	-166*	601	529	404	-514*	605
Net earnings/(loss)	3,316	2,678	1,085*	2,195	1,313	2,462	76*	1,215	1,684	-11,908	1,762*	1,934	2,077	2,267	2,025*	1,608	1,429	1,283	2,372*	1,552
Noncontrolling Interest																			0*	6
Noncontrolling interest	-1	1	-1*	-6	2	6	4*	4	4	3	0*	6	4	5		2	8	5
Net earnings/(loss) attributable to BMS	3,317	2,677	1,087*	2,201	1,310	2,456	72*	1,211	1,680	-11,911	1,762*	1,928	2,073	2,262	2,022*	1,606	1,421	1,278	2,372*	1,546
Basic (usd per share)	1.62	1.31		1.08	0.64	1.21		0.6	0.83	-5.89		0.94	0.99	1.08		0.75	0.67	0.6		0.7
Diluted (usd per share)	1.62	1.31		1.08	0.64	1.2		0.6	0.83	-5.89		0.93	0.99	1.07		0.75	0.66	0.59		0.69
Total Revenues — Netproductsales																10,813	11,485	11,308	11,609*	11,243
Total Revenues — Net Product Sales	12,588	11,168	12,111*	11,850	11,909	10,886	11,811*	11,483	11,925	11,559	11,168*	10,645	10,917	11,048
Total Revenues — Allianceandotherrevenues																405	402	340	376*	381
Total Revenues — Allianceandotherrevenues				372	360	315		409	276	306		321	309	289
Total Revenues — Alliance And Other Revenues	385	321